Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP313284.RAuXPSnoGMY8T1uOMYmcML2cD0Lc0dXQk4dK3nCfIBGLA#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 23658459 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Dovitinib was then evaluated in a phase II trial that included 4 groups of patients with human EGF receptor 2-negative metastatic breast cancer on the basis of FGFR1 amplification and hormone receptor (HR) status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.